Association between triglyceride-glucose index and all-cause mortality in non-diabetic patients with fibrotic lung disease receiving antifibrotic therapy: A retrospective cohort study
Aysegul Erinc, Ali Kirac, Fatma Ezgi Altun Acar, Abdullah Cagri Onal, Erdogan Cetinkaya · 2026
Read Association between triglyceride-glucose index and all-cause mortality in non-diabetic patients with fibrotic lung disease receiving antifibrotic therapy: A retrospective cohort study by Aysegul Erinc, Ali Kirac, Fatma Ezgi Altun Acar, Abdullah Cagri Onal, Erdogan Cetinkaya (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13537551.txt.
Description
Aysegul Erinc, Ali Kirac, Fatma Ezgi Altun Acar, Abdullah Cagri Onal, and Erdogan Cetinkaya test a blood score as a death risk mark in scarred lung illness in a 2026 study. The score blends fat and sugar levels in the blood as a stand-in for insulin strain. Its link to death in non-diabetic patients on scar-fighting drugs was not clear.
The team checked 144 patients treated from 2015 to 2023, with a median follow-up near 34 months. In that span, 54 patients died. Once other facts were weighed, the blood score showed no firm link to death. Low lung volume and heavy smoke history did track with death, the team found.
Catalog record
| CREATOR | Aysegul Erinc, Ali Kirac, Fatma Ezgi Altun Acar, Abdullah Cagri Onal, Erdogan Cetinkaya |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |